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Abstract Automated structural magnetic resonance
imaging (MRI) processing pipelines are gaining popularity
for Alzheimer’s disease (AD) research. They generate
regional volumes, cortical thickness measures and other
measures, which can be used as input for multivariate
analysis. It is not clear which combination of measures and
normalization approach are most useful for AD classifica-
tion and to predict mild cognitive impairment (MCI) con-
version. The current study includes MRI scans from 699
subjects [AD, MCI and controls (CTL)] from the Alzhei-
mer’s disease Neuroimaging Initiative (ADNI). The Free-
surfer pipeline was used to generate regional volume,
cortical thickness, gray matter volume, surface area, mean
curvature, gaussian curvature, folding index and curvature
index measures. 259 variables were used for orthogonal
partial least square to latent structures (OPLS) multivariate
analysis. Normalisation approaches were explored and the
optimal combination of measures determined. Results
indicate that cortical thickness measures should not be
normalized, while volumes should probably be normalized
by intracranial volume (ICV). Combining regional cortical
thickness measures (not normalized) with cortical and
subcortical volumes (normalized with ICV) using OPLS
gave a prediction accuracy of 91.5 % when distinguishing
AD versus CTL. This model prospectively predicted future
decline from MCI to AD with 75.9 % of converters cor-
rectly classified. Normalization strategy did not have a
significant effect on the accuracies of multivariate models
containing multiple MRI measures for this large dataset.
The appropriate choice of input for multivariate analysis in
AD and MCI is of great importance. The results support the
use of un-normalised cortical thickness measures and vol-
umes normalised by ICV.
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Introduction
Alzheimer’s disease (AD) is the most common form of
dementia in the ageing population of today. The estimated
cost of dementia worldwide has been calculated as 315.4
billion USD based on an estimated 29.3 million demented
patients in 2005 (Wimo et al. 2007). The number of
patients with AD has been predicted to quadruple by 2050
(Brookmeyer et al. 2007). The disease is characterized by a
gradual loss of cognitive functions, such as episodic
memory. The two major pathological hallmarks of AD are
extracellular plaques and intracellular tangles. Plaques and
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tangles are built of aggregates of Ab (Glenner and Wong
1984; Masters et al. 1985) and hyperphosphorylated tau
(Goedert et al. 1991), respectively. Other characteristics of
AD are synaptic loss and neuronal cell death, leading to
brain atrophy. Magnetic resonance imaging (MRI) pro-
vides structural information about the brain and has for
many years been widely used for early detection and
diagnosis of AD (O’Brien 2007; Ries et al. 2008). The way
in which AD atrophy progresses through the brain has been
described by Braak and Braak (1991). Atrophy typically
starts in the medial temporal and limbic areas, subse-
quently spreading to parietal association areas and finally
to frontal and primary cortices. For many years studies
have focused on single structures in the medial temporal
lobe for the early diagnosis of AD, such as hippocampus
and entorhinal cortex (Fox et al. 1996; Jack et al. 1992,
1997; Juottonen et al. 1999). In recent years however,
research has focused on combining different regions to
look at patterns of atrophy instead of single measures and
the former approach has proven to be more sensitive
(McEvoy et al. 2011; Westman et al. 2011c; Zhang et al.
2011). MRI is today an integrated part of the suggested
research (Dubois et al. 2007) and diagnostic criterion
(McKhann et al. 2011) alongside cerebrospinal fluid (CSF)
markers and positron emission tomography (PET).
Freesurfer is a highly automated structural MRI image
processing pipeline which produces regional volume, cor-
tical thickness, gray matter volume, surface area, mean
curvature, gaussian curvature, folding index and curvature
index measures. Automated image analysis pipelines may
have particular advantages when it comes to widespread
uptake in either clinical or research practice. Manual
measures of different brain regions are time consuming and
operator dependent and therefore not always practical in a
clinical settings. However, automated tools must be pre-
cise, accurate, fast and must be validated and tested on
large cohorts. Several groups have utilized automated
pipelines in AD research (Cui et al. 2011; Li et al. 2011;
McEvoy et al. 2009, 2011). We have also previously used
automated image analysis pipeline output analyzed with
multivariate tools for the purpose of AD classification and
to predict conversion from the prodromal stage of the
disease, mild cognitive impairment (Westman et al., 2011a,
b). Different regional MRI measures have been used in the
studies reported in the literature including our own and
different approaches have been taken to normalization. For
example, should regional volumes be normalized by
dividing by intracranial volume to reflect differences in
head size between individuals, particularly males and
females, and pre-morbid brain size? It is not clear yet
which combination of regional measures and which nor-
malization approaches yield the best results for individual
classification and prediction.
The current study investigated the use of regional MRI
measures analyzed by orthogonal partial least square to
latent structure (OPLS) a multivariate tool for classification
of individual subjects. The specific aims were to determine:
(1) which type of normalization approach is most useful for
the different regional measures (2) which combination of
regional measures results in the best classification accuracy
when distinguishing between AD subjects and healthy
controls, and (3) to prospectively predict conversion from
MCI to AD at baseline by appropriate choice of multi-
variate model. We hypothesized that regional volumetric
measures would give the best results when normalized by
total intracranial volume, that surface area should be nor-
malized by whole brain surface area, while the remaining
measures (cortical thickness, mean curvature, gaussian
curvature, folding index and curvature index) should not be
normalized. Further, we hypothesized that a combination
of regional subcortical volumes normalized by intracranial
volume and un-normalized cortical thickness measures
would generate the most accurate predictions.
Materials and Methods
Data
Data was downloaded from the Alzheimer’s disease
Neuroimaging Initiative (ADNI) database (www.loni.ucla.
edu/ADNI, PI Michael M. Weiner). ADNI was launched in
2003 by the National Institute on Aging (NIA), the
National Institute of Biomedical Imaging and Bioengi-
neering (NIBIB), the Food and Drug Administration
(FDA), private pharmaceutical companies and non-profit
organizations, as a $60 million, 5-year public–private
partnership. The primary goal of ADNI has been to test
whether serial MRI, PET and other biological markers are
useful in clinical trials of MCI and early AD. Determina-
tion of sensitive and specific markers of very early AD
progression is intended to aid researchers and clinicians to
develop new treatments and monitor their effectiveness, as
well as lessen the time and cost of clinical trials. ADNI
subjects aged 55–90 from over 50 sites across the U.S. and
Canada participated in the research and more detailed
information is available at www.adni-info.org.
Inclusion and Diagnostic Criteria
A total of 699 subjects were included in the current study
(AD = 187, MCI = 287 and CTL = 225). The demo-
graphics of the cohort are given in Table 1. We included all
subjects who had successful MRI measures at baseline
which passed the quality control steps outlined below. Out
of the 287 MCI subjects, 87 had converted at the 18-month
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follow-up (MCIc) to Alzheimer’s disease. Subjects which
did not convert to Alzheimer’s disease at 18 month follow
up are referred to as MCI stable (MCIs) here.
A detailed description of the inclusion criteria can be
found on the ADNI webpage (http://www.adni-info.org/
Scientists/AboutADNI.aspx#). Subjects were between 55
and 90 years of age. They had a study partner able to
provide an independent evaluation of functioning, and
spoke either English or Spanish. All subjects were willing
and able to undergo all test procedures including neuro-
imaging and agreed to longitudinal follow up. Specific
psychoactive medications were excluded.
Alzheimer’s disease (General inclusion/exclusion cri-
teria): (1) Mini mental state examination (MMSE) scores
between 20 and 26, (2) Clinical dementia rating scale
(CDR) of 0.5 or 1.0, 3) met NINCDS/ADRDA criteria for
probable AD, (3) Geriatric Depression Scale \6, (4) Sub-
jects excluded if they had any other significant neurologic
disease other than Alzheimer’s disease.
Mild cognitive impairment (General inclusion/exclusion
criteria): (1) subjects had MMSE scores between 24 and 30
(inclusive), (2) memory complaint, with objective memory
loss measured by education adjusted scores on the Wechsler
Memory Scale Logical Memory II, (3) CDR of 0.5, (4)
absence of significant levels of impairment in other cognitive
domains, essentially preserved activities of daily living, and
an absence of dementia, (5) Geriatric Depression Scale\6,
(6) Subjects excluded if they had any other significant neu-
rologic disease other than Alzheimer’s disease.
Controls (General inclusion/exclusion criteria): (1)
MMSE scores between 24 and 30 inclusive, (2) CDR of
zero, (3) they were non-depressed, non MCI, and non-
demented.
MRI
MRI data was downloaded from the ADNI website (www.loni.
ucla.edu/ADNI). A description of the data acquisition for the
ADNI study can be found at www.loni.ucla.edu/ADNI/
research/Cores/index.shtml. Briefly, 1.5T MRI data was col-
lected from a variety of MR-systems with protocols optimized
for each type of scanner. The MRI protocol included a high
resolution sagittal 3D T1-weighted MPRAGE volume (voxel
size 1.1 9 1.1 9 1.2 mm3) acquired using a custom pulse
sequence specifically designed for the ADNI study to ensure
compatibility across scanners. Full brain and skull coverage
was required for the MRI datasets and detailed quality control
carried out on all MR images from both studies according to
previously published quality control criteria (Simmons et al.
2009, 2011).
Regional Volume Segmentation and Cortical Thickness
Parcellation
We utilized the Freesurfer pipeline version 5.1.0 (http://
surfer.nmr.mgh.harvard.edu/), which includes removal of
non-brain tissue using a hybrid watershed/surface defor-
mation procedure (Segonne et al. 2004), automated Talai-
rach transformation, segmentation of the subcortical white
matter and deep grey matter volumetric structures (Fischl
et al. 2002; Fischl et al. 2004a; Segonne et al. 2004)
intensity normalization (Sled et al. 1998), tessellation of
the grey matter white matter boundary, automated topology
correction (Fischl et al. 2001; Segonne et al. 2007), and
surface deformation following intensity gradients to opti-
mally place the grey/white and grey/cerebrospinal fluid
borders at the location where the greatest shift in intensity
defines the transition to the other tissue class (Dale et al.
1999; Dale and Sereno 1993; Fischl and Dale 2000). Once
the cortical models are complete, registration to a spherical
atlas takes place which utilizes individual cortical folding
patterns to match cortical geometry across subjects (Fischl
et al. 1999). This is followed by parcellation of the cerebral
cortex into units based on gyral and sulcal structure
(Desikan et al. 2006; Fischl et al. 2004b). The pipeline
generated 68 cortical thickness, cortical volume, surface
Table 1 Subject characteristics
AD (n = 187) MCI (n = 287) CTL (n = 225) MCIs (n = 200) MCIc (n = 87) p
Female/male 88/99 104/183 108/117 66/134 38/49 –
Age 75.4 ± 7.5 74.9 ± 7.0 75.9 ± 5.1 74.7 ± 7.1 75.2 ± 6.9 –
Education 14.7 ± 3.1 15.8 ± 3.0 16.1 ± 2.9 15.9 ± 3.0 15.4 ± 3.0 –
MMSE 23.3 ± 2.0a,b 27.1 ± 1.7b 29.1 ± 1.0 27.4 ± 1.7 26.5 ± 1.7 \0.001
CDR 0.7 ± 0.3a,b 0.5b 0 0.5 0.5 \0.001
Data are represented as mean ± standard deviation
Two-way Student t test with Bonferroni correction was used for age and education and neuropsychological tests comparisons. a Significant
compared to MCI group. b Significant compared to control group
AD Alzheimer’s disease, MCI mild cognitive impairment, CTL healthy control, Education in years, MMSE mini mental state examination,
ADAS1 Word list non-learning (mean), CDR clinical dementia rating. Chi-square was used for gender comparison
Brain Topogr (2013) 26:9–23 11
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area, mean curvature, gaussian curvature, folding index and
curvature index measures (34 from each hemisphere) and 46
regional subcortical volumes. Volumes of white matter hy-
pointensities, optic chiasm, right and left vessel, and left and
right choroid plexus were excluded from further analysis.
Cortical thickness and volumetric measures from the right
and left side were averaged (Fjell et al. 2009; Walhovd et al.
2011). In total 259 variables obtained from the pipeline were
used as input variables for the OPLS classification, 34 cor-
tical regions (7 types of measures) and 21 regional volumes
(Table 2). Figure 1 illustrates the location of both the cor-
tical and subcortical regions. This segmentation approach
has been used for multivariate classification of Alzheimer’s
disease and healthy controls (Westman et al. 2011d), neu-
ropsychological-image analysis (Liu et al. 2010c, 2011),
imaging-genetic analysis (Liu et al. 2010a, b) and biomarker
discovery (Thambisetty et al. 2010).
Normalization
We wished to compare the effect of different normalisation
approaches on multivariate analysis to determine which
gave the best discriminant and predictive performance. To
this end we normalised the various MRI measures in a
series of ways. All sets of regional MRI measures from
each subject were considered in their raw form and also
normalized by the subject’s intracranial volume. Further,
the cortical thickness measures and the surface area mea-
sures from each subject were also normalized by the sub-
ject’s average global cortical thickness and the subject’s
total surface area respectively.
Statistical Analysis
MRI measures were analyzed using OPLS (Bylesjo et al.
2007; Trygg and Wold 2002; Rantalainen et al. 2006;
Westman et al. 2011c, 2010; Wiklund et al. 2008), a
supervised multivariate data analysis method included in
the software package SIMCA (Umetrics AB, Umea,
Sweden). A very similar method, partial least squares to
latent structures (PLS) has previously been used in several
studies to analyze MR-data (Levine et al. 2008; McIntosh
and Lobaugh 2004; Oberg et al. 2008; Westman et al.
2009, 2007). OPLS and PLS give the same predictive
accuracy, but the advantage of OPLS is that the model
created to compare groups is rotated, which means that the
information related to class separation is found in the first
component of the model, the predictive component. The
other orthogonal components in the model, if any, relate to
variation in the data not connected to class separation.
Focusing the information related to class separation on the
first component makes data interpretation easier (Wiklund
et al. 2008). There are also many similarities between
linear support vector machine (SVM) and OPLS. Both
methods can handle datasets with more dimensions than
samples. Linear SVM weights illustrate the importance of
the variables for the classification in descending order in
the same way as the loadings plots do for OPLS. The
unique property of OPLS when compared to other linear
regression methods is its ability to separate the modeling of
Table 2 Variable included in OPLS analysis
Cortical measuresa Subcortical measuresb
Banks of superior temporal sulcus Third ventricle
Caudal anterior cingulate Fourth ventricle
Caudal middle frontal gyrus Inferior lateral ventricle
Cuneus cortex Lateral ventricle
Entorhinal cortex Cerebrospinal fluid (CSF)
Fusiform gyrus Accumbens
Inferior parietal cortex Amygdala
Inferior temporal gyrus Brainstem
Isthmus of cingulate cortex Caudate
Lateral occipital cortex Cerebellum cortex
Lateral orbitofronral cortex Cerebellum white matter
Lingual gyrus Corpus callosum anterior
Medial orbitalfrontal cortex Corpus callosum central
Middle temporal gyrus Corpus callosum midanterior
Parahippocampal gyrus Corpus callosum
midposterior
Paracentral sulcus Corpus callosum posterior
Frontal operculum Hippocampus
Orbital operculum Putamen
Triangular part of inferior frontal
gyrus
Pallidum
Pericalcarine cortex Thalamus proper




Rostral anterior cingulate cortex









259 variables in total included in OPLS analysis
a Cortical measures = 34 regions (cortical volumes, cortical thick-
ness, surface area, mean curvature, gaussian curvature, folding index
and curvature index)
b Subcortical measures = 21 regions (volumes)
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correlated variation from structured noise (uncorrelated
variation). The structured noise is defined as orthogonal
variation in Y. At the same time the model maximizes the
covariance between X and Y.
Pre-processing was performed using mean centring and
unit variance scaling. Mean centring improves the inter-
pretability of the data, by subtracting the variable average
from the data. By doing so the data set is repositioned
around the origin. Large variance variables are more likely
to be expressed in modeling than low variance variables.
Consequently, unit variance scaling was selected to scale
the data appropriately. This scaling method calculates the
standard deviation of each variable. The inverse standard
deviation is used as a scaling weight for each MR-measure.
The results from the OPLS analysis are visualized in a
scatter plot by plotting the predictive component, which
contains the information related to class separation. Com-
ponents are vectors, which are linear combinations of
partial vectors and are dominated by the input variables (x),
in this case the regional MRI output. Each point in the
scatter plot represents one individual subject.
Each model receives a Q2(Y) value that describes its
statistical significance for separating groups. Q2(Y) values
[0.05 are regarded as statistically significant (Umetrics
2008), where
Q2ðYÞ ¼ 1  PRESS/SSY ð1Þ
where PRESS (predictive residual sum of squar-
es) = R(yactual - ypredicted)
2 and SSY is the total variation of
the Y matrix after scaling and mean centring (Eriksson et al.
2006). Q2(Y) is the fraction of the total variation of the Ys
(expected class values) that can be predicted by a component
according to cross validation (CV). CV is a statistical method
for validating a predictive model which involves building a
number of parallel models. These models differ from each other
by leaving out a part of the data set each time. The data omitted
is then predicted by the respective model. In this study we used
seven fold CV, which means that 1/7th of the data is omitted for
each CV round. Data is omitted once and only once.
Variables can be plotted according to their importance
for the separation of groups. The plot shows the MRI
measures and their corresponding jack-knifed confidence
intervals. Jack-knifing is used to estimate the bias and
standard error. Measures with confidence intervals that
include zero have low reliability (Wiklund et al. 2008).
Covariance is plotted on the y-axis, where
Covðt; XiÞ ¼ tT Xi=ðN  1Þ ð2Þ
where t is the transpose of the score vector t in the
OPLS model, i is the centered variable in the data matrix X
and N is the number of variables (Wiklund et al. 2008).
Fig. 1 Representations of ROIs included as candidate input variables
in the multivariate OPLS model. a Coronal view of a T1-weighted
MPRAGE image displaying the regional volumes. b Lateral and
medial views of the grey matter surface illustrating the 34 regional
cortical thickness measures
Brain Topogr (2013) 26:9–23 13
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A measure with high covariance is more likely to have an
impact on group separation than a variable with low
covariance. MRI measures below zero in the scatter plot
have lower values in AD subjects compared to CTL
subjects, while MRI measures above zero are higher in AD
subjects compared to CTL subjects in the model.
Altogether eight types of regional MRI measures were
used (cortical thickness, cortical volumes, subcortical
Table 3 Raw data (data not normalized)
QledoM 2 CUAyticificepSytivitisneSycaruccA)Y(
Cortical thickness (CT) 0.522 85.2 (81.4-88.3
Cortical volumes (CV) 0.467 81.8 (77.8-85.2) 84.0 (78.0-88.5) 80.0 (74.3-84.7) 0.909*
Subcortical volumes (SV) 0.459 82.5 (78.6-85
Mean curvature (MC) 0.195 69.9 (65.3-74.1) 63.6 (56.5-70.2) 72.0 (65.8-77.5) 0.759
Surface area (SA) 0.164 67.2 (62.6-71.6) 
Gausian curvature (GC) ns -   -   -   - 
Folding index (FI)* ns -   -   -   - 
Curvature index (CI) ns -   -   -   - 
Average 












SV+CV+CT 0.626 90.5 (87.3-93.0) 89.8 
) 82.4 (76.3-87.2) 87.6 (82.6-91.3) 0.927**
.9) 82.4 (76.3-87.5) 82.7 (77.2-87.1) 0.898
69.0 (62.0-75.2) 65.8 (59.4-71.7) 0.740
77.3 76.3 77.6 0.847
4.1-93.0) 90.2 (85.6-93.5) 0.951
2.8-92.1) 88.9 (84.1-92.4) 0.950
1.6-91.2) 89.3 (84.6-92.7) 0.949
1.0-90.8) 88.9 (84.1-92.4) 0.948*
2.2-91.7) 85.3 (80.1-89.4) 0.941*
2.8-92.1) 83.1 (77.7-87.4) 0.933*
9.8-89.9) 85.8 (80.6-89.7) 0.936
6.8-87.6) 85.8 (80.6-89.7) 0.934*
87.1 86.9 87.4 0.943
(84.6-93.4) 91.1 (86.7-94.2) 0.958
Q2(Y) = predictive ability of model and AUC = area under the curve. Confidence interval within parentheses. Thick line separating models
(within the table content) means that the block of models are significantly different in AUC compared to the other models in that category of
normalization method and number of input measures
* Significant difference in AUC between raw data versus normalized with intra cranial volume. ** Significant difference in AUC between raw
data and normalized with intra cranial volume and raw data versus normalized with mean cortical thickness. P-values \0.05 considered
significant after Bonferroni correction
Table 4 Data normalized by intra cranial volume
Model Q2(Y) CUAyticificepSytivitisneSycaruccA
Cortical volume (CV) 0.495 83.5 (79.6-86.8
Cortical thickness (CT) 0.491 83.3 (79.4-86.6) 80.8 (74.5-85.8) 85.3 (80.1-89.4) 0.917*
Subcortical volume (SV) 0.453 82.5 (78.6-85
Mean curvature (MC) 0.210 69.4 (64.8-73.7) 64.2 (57.1-70.7) 73.8 (67.7-79.1) 0.773


















) 85.0 (79.2-89.4) 82.2 (76.7-86.7) 0.920*
.9) 81.3 (75.1-86.2) 83.6 (78.2-87.8) 0.896
(83.4-92.5) 90.7 (86.2-93.8) 0.960
(82.2-91.7) 88.9 (84.1-92.4) 0.950
(81.6-91.2) 88.9 (84.1-92.4) 0.952
(82.8-92.1) 86.7 (81.6-90.5) 0.954*
(78.0-88.5) 87.6 (82.6-91.3) 0.945
(81.0-90.8) 84.9 (79.6-89.0) 0.938*
(76.3-87.5) 85.8 (80.6-89.7) 0.942
(82.8-92.1) 91.1 (86.7-94.2) 0.953
Q2(Y) = predictive ability of model and AUC = area under the curve. Confidence interval within parentheses. Thick line separating models
(within the table content) means that the block of models are significantly different in AUC compared to the other models in that category of
normalization method and number of input measures
* Significant difference in AUC between raw data versus normalized with intra cranial volume. P-values \0.05 considered significant after
Bonferroni correction
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volumes surface area, mean curvature, gaussian curvature,
folding index and curvature index), resulting in a total of 259
variables to be used for OPLS analysis (Table 2). A series of
OPLS models were created for comparing the CTL versus
AD groups. For each of the eight types of measures, both raw
measures and measures normalized by intracranial volume
(ICV) were used in these models. In addition cortical
thickness measures were also normalised by mean cortical
thickness and surface area measures by total surface area.
Subsequently hierarchical models consisting of combina-
tions of two or three sets of regional measures were also
created (for example raw cortical thickness measures and
raw subcortical volumes, or cortical thickness measures
normalised by intracranial volume and subcortical volumes
normalised by intracranial volume). Feature selection was
not used other than excluding measures which resulted in
non-significant models. Excluding specific regions from the
models might make the models less representative and
structural features measured from a limited set of pre-defined
regions might not be able to reflect the pattern of structural
abnormalities in their entirety (Zhang et al. 2011). Further,
Cuignet et al. (2011) showed that feature selection does not
improve the classification but it does increase the computa-
tional time. Another recent paper investigated the effect of
feature selection (Chu et al. 2012) and they concluded that
feature selection improves the results particularly for small
cohorts but it does not seem to have a great affect on larger
samples. We have a much larger sample than the largest
sample used in this latter study.
The MCI subjects were also assessed against the best
CTL versus AD models to investigate how well the model
could predict conversion at 18 month follow-up from
baseline. Sensitivity, specificity, accuracy and area under
the receiver operating characteristic curve (AUC) of the
different models were calculated from the cross-validated
prediction values of the OPLS models. Areas under the
receiver operating characteristic curve were compared by
using the method of Hanley and McNeil (1983; McEvoy
et al. 2011), p-values \0.05 after correcting for multiple
comparisons using Bonferroni correction were considered
statistically significant.
The two-way Student t test with Bonferroni correction
(p-values [ 0.05 considered significant) was used for uni-
variate analysis to investigate the effect of normalization of
single regional measures (Tables 6; 7).
Results
OPLS models were created using CTL versus AD data for
all eight types of regional MRI measures (cortical thick-
ness, cortical volume, subcortical volume, surface area,
mean curvature, gaussian curvature, folding index and
curvature index) for both raw data and normalized data.
Hierarchical models were also created using up to three
types of different regional MRI measures. No feature
selection was performed for any of the eight different types
of measures, meaning all data was included.
Modeling and quality parameters are only shown for the
statistically significant single measure models and the most
robust [highest Q2(Y)] hierarchical models (Table 3: raw
data, Table 4: ICV normalized data, Table 5: data normal-
ized by total surface area, average cortical thickness and
mixed models including both normalized and raw data).
Figure 2 shows the variables of importance for the three
most robust single measure models [subcortical volumes
(ICV normalized), cortical volumes (ICV normalized) and
cortical thickness measures (raw data)]. Variables of
greatest importance for the separation between groups were
as expected the medial temporal lobe structures such as
hippocampus, amygdala and entorhinal cortex. To illustrate
the effect of normalization approaches on single measures
univariate analysis was performed for subcortical volumes
(Table 6), cortical volumes and cortical thickness measures
Table 5 Other normalization models
Model Q2(Y) Accuracy Sensitivity Specificity AUC
CT (normalized with average CT) 0.476 83.7 (80.0-87.0) 83.0 (76.8-87.6) 84.8 (79.6-88.9) 0.912**
SA (normalized with total SA) 0.169 69.2 (64.6-73.4) 71.1 (64.3-77.4) 67.6 (61.2-73.3) 0.744
Hierarchial model
SV ? CT* 0.603 89.3 (86.0-92.0) 87.2 (81.6-91.2) 91.1 (86.7-94.2) 0.951
CV ? CT* 0.592 88.4 (84.9-91.1) 86.6 (81.0-90.8) 89.8 (85.1-93.1) 0.951
Hierarchial model
SV ? CV ? CT* 0.626 91.5 (88.4-93.8) 89.8 (86.5-92.4) 92.9 (88.8-95.6) 0.960
Q2(Y) = predictive ability of model, CV cortical volume, SV subcortical volume, CT cortical thickness, SA surface area and AUC area under the
curve. Confidence interval within parentheses. * Mixed model = SV and CV normalized by ICV with raw CT data. ** Significant difference in
AUC between raw data and normalized with mean cortical thickness. P-values \0.05 considered significant after Bonferroni correction
Brain Topogr (2013) 26:9–23 15
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(Table 7). As can be observed in Tables 6 and 7, normal-
izing volumes with ICV and raw cortical thickness mea-
sures gave the best results.
AD Classification and MCI Conversion
The results from the different models used for AD classifi-
cation can be observed in Tables 3, 4, 5. The AUC values for
the different models were compared using the method of
Hanley and McNeil and p-values \0.05 after Bonferroni
correction for multiple comparisons were considered sta-
tistically significant. Only five out of the eight single mea-
sure models gave significant results for both raw and
normalized data. Gaussian curvature, folding index and
curvature index were therefore excluded from further anal-
ysis. Out of the five remaining measures the best results were
obtained from the cortical thickness, cortical volume and
subcortical volume measures (these measures were signifi-
cantly different from surface area and mean curvature for



































































































































































































































































































































































































































































































































































































































































































































































Fig. 2 Variables of importance
for the separation between CTL
versus AD. a subcortical
volumes (normalized by intra
cranial volume) b cortical gray
matter volumes (normalized by
intra cranial volume) c cortical
thickness (raw data). Measures
above zero have a larger value
in AD compared to controls and
measures below zero have a
lower value in AD compared to
controls. A measure with a high
covariance is more likely to
have an impact on group
separation than a measure with a
low covariance. Measures with
jack knifed confidence intervals
that include zero have low
reliability
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the best discrimination was obtained for cortical thickness
measures with an accuracy of 85.2 % (significantly different
from cortical and subcortical volumes) and for data nor-
malized by ICV the best discrimination was obtained from
the cortical volumes with an accuracy of 83.5 % (signifi-
cantly different from cortical thickness and subcortical
volumes). Looking at the normalization approaches for the
single measures, a significantly better result was obtained for
the cortical thickness measures when the data was not nor-
malized, compared to normalization with ICV and mean
cortical thickness (85.2 % compared to 83.5 and 83.7 %
respectively). For cortical volumes it was significantly better
to normalize with ICV than to use raw data (83.5 % com-
pared to 81.8 %). For the other measures normalization did
not have an effect. Figure 3 shows the scatter plots for the top
three single measures (raw data cortical thickness and ICV
normalized cortical and subcortical volumes) illustrating the
separation between the AD and CTL groups.
For the hierarchical models containing a combination of two
different measures the best models were the combination of
subcortical volumes with either cortical thickness or cortical
volumes for both raw data and ICV normalization (Raw data:
subcortical volumes ? cortical thickness = 89.8 %, subcor-
tical volumes ? cortical volumes = 88.6 %. ICV normalized
data: subcortical volumes ? cortical volumes = 89.8 %,
subcortical volumes ? cortical thickness = 88.4 %). There
seemed to be no effect of normalization approaches for the
most accurate and robust models combining two different
measures. No effect of normalization approach was observed
either for the models containing three different measures.
Combining three different measures did not significantly
affect the prediction accuracy compared to using two dif-
ferent measures. Only the three best models are shown
using the combination of cortical thickness, cortical vol-
ume and subcortical volumes. However, the best overall
prediction accuracy was obtained using this combination
with raw cortical thickness data and volumes normalized to
ICV (91.5 %).
Finally the best AD versus CTL models containing the
measures cortical thickness, cortical volumes and subcor-
tical volumes were used to predict conversion at 18 month
follow-up. Out of 287 MCI subjects 87 had converted to
AD at follow up. Similar results were observed for the MCI
predictions as for the models discriminating between AD
patients and cognitively normal subjects (Table 8). The
best results were obtained with a hierarchical model of two
sets of measures when subcortical volumes were combined
with either cortical volumes or cortical thickness. Com-
bining the three measures did not improve the predictions
and normalization approach did not seem to significantly
affect the results either. The best results were obtained
from the two models combining cortical thickness with
subcortical volumes (both ICV normalized data and mixed
data where the volumes are normalized to ICV and the raw
cortical thickness data was used) with 77 % of the MCIc
subjects correctly classified.
Discussion
The Freesurfer pipeline has been utilized in a number of
studies for AD classification and predicting MCI conver-
sion (Cui et al. 2011; Cuingnet et al. 2011; McEvoy et al.
2009, 2011; Westman et al. 2011a, b), but the complete
range of measures which can be obtained have not yet been
fully explored.
Normalization
The way in which different regional measures such as
volumes and cortical thickness should be normalized is
very important. Previous studies (Barnes et al. 2010; Cui
et al. 2011; Farias et al. 2011; Fjell et al. 2009; Walhovd
Table 6 Univariate analysis of subcortical volumes using different
normalization approaches for AD versus CTL
Subcortical measures Subcortical volumes
Normalization Raw ICV
Third ventricle ns p < 0.01
Fourth ventricle ns ns
Inferior lateral ventricle p \ 0.00001 p \ 0.00001
Lateral ventricle p \ 0.00001 p \ 0.00001
Cerebrospinal fluid (CSF) P \ 0.001 p \ 0.00001
Accumbens p \ 0.00001 p \ 0.00001
Amygdala p \ 0.00001 p \ 0.00001
Brainstem ns p < 0.00001
Caudate ns ns
Cerebellum cortex ns ns
Cerebellum white matter ns ns
Corpus callosum anterior ns ns
Corpus callosum central p \ 0.001 p \ 0.001
Corpus callosum midanterior p \ 0.01 p < 0.001
Corpus callosum midposterior p \ 0.001 p < 0.00001
Corpus callosum posterior ns p < 0.01
Hippocampus p \ 0.00001 p \ 0.00001
Putamen ns ns
Pallidum ns ns
Thalamus proper ns ns
Ventral diencephalon (DC) p \ 0.001 p < 0.00001
Bold values illustrate that there are differences in normalization
method
AD = Alzheimer’s disease, CTL = healthy control, ICV = intra
cranial volume and raw = not normalized. Two-way Student t test
with Bonferroni correction is used for univariate analysis. P-val-
ues \0.05 considered significant after Bonferroni correction
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et al. 2011; Westman et al. 2011b) have utilized different
approaches which can make results difficult to compare.
The results from the present study indicate that cortical
thickness measures should not be normalized, while vol-
umes should probably be normalized to ICV. Normalizing
cortical volumes improved the classification accuracy
while normalizing subcortical volumes did not show any
statistically significant improvement using the single
measure OPLS multivariate models. Further, looking at the
single regions (Tables 6, 7), it seems that normalizing the
volumes results in the largest differences while using the
raw data for cortical thickness yields the best results. When
combining the different measures in multivariate models
the normalization effect disappears. A potential explana-
tion for this could be that the use of multiple regional
measures provides enough anatomical information about
the brain atrophy pattern such that multivariate models are
robust enough to handle the variation caused by different
normalization approaches. In a recent paper, the consis-
tency of volumetric measures derived by FreeSurfer was
Table 7 Univariate analysis of cortical thickness and volumes using different normalization approaches for AD versus CTL
Cortical measures Cortical thickness Cortical volume
Normalization Raw ICV Mean CT Raw ICV
Banks of superior temporal sulcus p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001
Caudal anterior cingulate ns ns p \ 0.00001 Ns ns
Caudal middle frontal gyrus p < 0.00001 p \ 0.001 ns Ns ns
Cuneus cortex ns ns p \ 0.00001 Ns ns
Entorhinal cortex p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001
Fusiform gyrus p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001
Inferior parietal cortex p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001
Inferior temporal gyrus p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001
Isthmus of cingulate cortex p < 0.00001 p \ 0.001 ns p \ 0.001 p < 0.00001
Lateral occipital cortex p < 0.00001 p \ 0.05 ns Ns p < 0.001
Lateral orbitofronral cortex p < 0.00001 ns ns Ns p < 0.05
Lingual gyrus p < 0.00001 ns p \ 0.01 p \ 0.05 p < 0.01
Medial orbitalfrontal cortex p < 0.00001 p \ 0.01 Ns p \ 0.01 p < 0.00001
Middle temporal gyrus p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001
Parahippocampal gyrus p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001
Paracentral sulcus ns ns p \ 0.00001 Ns ns
Frontal operculum p \ 0.00001 ns p \ 0.00001 Ns ns
Orbital operculum p < 0.00001 ns ns p \ 0.05 p < 0.01
Triangular part of inferior frontal gyrus p < 0.00001 ns p \ 0.01 p \ 0.01 p < 0.001
Pericalcarine cortex ns ns p \ 0.00001
Postcentral gyrus p < 0.01 ns p \ 0.00001 p < 0.01
Posterior cingulate cortex p < 0.001 ns p \ 0.01 p \ 0.01 p < 0.00001
Precentral gyrus p < 0.001 ns
Precuneus cortex p < 0.00001 p \ 0.00001 p \ 0.00001 p \ 0.00001
Rostral anterior cingulate cortex ns ns p \ 0.01 Ns ns
Rostral middle frontal gyrus p < 0.00001 p \ 0.001 ns p \ 0.001 p < 0.00001
Superior frontal gyrus p < 0.00001 p \ 0.01 ns p \ 0.01 p < 0.00001
Superior parietal gyrus p < 0.00001 p \ 0.01 ns p \ 0.01 p < 0.00001
Superior temporal gyrus p < 0.00001 p \ 0.00001 ns p \ 0.00001 p \ 0.00001
Supramarginal gyrus p < 0.00001 p \ 0.00001 ns p \ 0.00001 p \ 0.00001
Frontal pole p < 0.001 ns ns p \ 0.001 p \ 0.001
Temporal pole p < 0.00001 p \ 0.00001 ns p \ 0.00001 p \ 0.00001
Transverse temporal cortex ns ns ns Ns p < 0.01
Insular p < 0.00001 ns ns Ns p < 0.0001
Bold values illustrate that there are differences in normalization method
AD = Alzheimer’s disease, CTL = healthy control, ICV = intra cranial volume, Raw = not normalized and mean CT = normalized by mean
cortical thickness. Two-way Student t test with Bonferroni correction is used for univariate analysis
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investigated in five different cohorts (a total of 883 sub-
jects) (Walhovd et al. 2011). This study normalized
regional volume measurements by ICV as we propose here.
They concluded that ICV normalization is the most com-
monly used normalization approach in the literature.
However, it has also been stated that normalizing to ICV is
unlikely to be adequate due to the non-linear relationship
between volumes and ICV which was found in a sample of
78 healthy controls (Barnes et al. 2010). Another recent
study also stated that normalizing volumes to ICV is
inadequate due to the fact that the maximal brain size
seems to be an important predictor of cognition in old age,
independent of brain pathology (Farias et al. 2011). By
normalizing to ICV, the authors claim that investigators
may overlook the effect of ICV itself. Especially in
longitudinal studies, ICV may be an important variable in
itself for quantifying the effect of brain reserve (Farias
et al. 2011). Reviewing the literature regarding normalizing
cortical thickness, there seems to be a common agreement
that these measures should not be normalized (Fjell et al.
2009). This is also confirmed in the present study, where
normalized cortical thickness measures gave significantly
lower prediction accuracies regardless of normalization
approach (mean thickness or ICV).
Previous studies have drawn different conclusions on
the best normalization approach to adopt for regional MRI
measures. However, we feel fairly confident to say from
the results of the present study and results from previous
studies that cortical thickness should not be normalized.



































































Fig. 3 Scatter plots illustrating
the separation between CTL
versus AD. a subcortical
volumes (normalized by intra
cranial volume) b cortical gray
matter volumes (normalized by
intra cranial volume) c cortical
thickness (raw data). The scatter
plots visualise group separation
and the predictability of three
different AD versus CTL
models. Each black circle
represents an AD subject and
each gray square a control
subject. Control subjects to the
right of zero and AD subjects to
the left of zero are falsely
predicted
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issue however. We believe that considering single regions,
the best approach is to normalize to ICV. Even though the
relationship between ICV and volumes may not be linear
and the effect of ICV itself may be removed if data is
normalized, we still believe this may be the best approach
to take. This is due to the fact that changes in neurode-
generative disorders are relatively small and could be
overlooked if data is not normalized. When we consider
multivariate models containing multiple brain regions the
normalization approach does not seem to be that important.
This need to be further validated in larger studies.
AD Classification and MCI Conversion
Previous studies have utilized different types of regional
MRI measures for AD classification and to predict MCI
conversion (Cui et al. 2011; Cuingnet et al. 2011; McEvoy
et al. 2009, 2011; Westman et al. 2011a, b). Whole brain
volume, regional volumes and cortical thickness measures
(volumes normalized to ICV and raw cortical thickness
data) were included in a recent study (McEvoy et al. 2011).
This study obtained a prediction accuracy of 90.4 %
between AD and CTL using a smaller sample from the
same cohort as in this study (ADNI). This is very similar to
the best accuracies obtain in this study ranging between
89.3 and 91.5 %. Data from the ADNI cohort was also
utilized in another study, which included cortical thickness
measures and regional cortical and subcortical volumes
(data not normalized), to train a SVM classifier using AD
and CTL data (Cui et al. 2011). The MCI subjects were
then used as a test set (in the same way as in the present
study) to predict future conversion at baseline. Using the
measures mentioned above 57.1 % of the MCIc and
65.5 % of MCIs were correctly classified, compared to 77
and 65.0 % respectively in the present study.
Other recent studies which did not use Freesurfer as
input for multivariate analysis have also found results in
line with ours. SVM has been successfully utilized with
voxel based input with accuracies up to 90.8 % (Chu et al.
2012; Liu et al. 2012). Our results are also in line with
those of Zhang et al. (2011) who found a classification
accuracy of 93.2 % when combining ROI based MRI
measures with FDG-PET and CSF.
Conclusion
Automated MRI image analysis pipelines can be used as
input for multivariate data analysis and machine learning
techniques, but there is also the option of using raw images
as the input to similar multivariate or machine learning
approaches. One of the major advantages of automated
analysis pipelines is their use of a number of predefined
regions which are easy to interpret and have a defined
biological meaning. These have greater face validity as a
biomarker of disease than a complex pattern of individual
voxels across the brain (McEvoy et al. 2011). This study
demonstrates that combining raw cortical thickness mea-
sures with subcortical volumes normalized by intracranial
volume gives the best prediction accuracy for separating
AD subjects from cognitively normal subjects. Adding
further measures did not significantly improve the classi-
fication accuracy, most likely because these additional
measures are also derived from the same regions as the
cortical thickness measures and provide similar informa-
tion. Further, normalization approach does not seem to
have such a great effect as we initially hypothesized. We
do however believe that volumes should be normalized by
ICV and that raw cortical thickness data should be used,
especially when looking at single regions or measures. This
need to be further validated in alternative cohorts. Finally,
the combination of cortical thickness measures with sub-
cortical volumes shows potential for prospectively pre-
dicting future conversion to AD from baseline. We believe
this is a sensible approach using MRI patterns as a bio-
marker of disease. Combining this approach with other
biomarkers such as CSF markers (Westman et al. 2012)









SV ? CV 75.9 60.5 65.1 0.734
SV ? CT 74.7 62.5 66.2 0.746
CV ? CT 67.8 69.0 68.6 0.742
SV ? CV ? CT 75.9 64.0 67.6 0.753
Average 73.6 64.0 66.9 0.744
ICV normalized
SV ? CT 77.0 65.0 68.6 0.739
SV ? CV 75.9 60.5 65.1 0.729
CV ? CT 68.9 67.0 67.6 0.736
SV ? CV ? CT 73.5 64.0 66.9 0.743
Average 73.8 64.1 67.1 0.737
Mixed models*
SV ? CT 77.0 64.5 68.3 0.749
CV ? CT 70.1 67.0 67.9 0.743
SV ? CV ? CT 75.9 66.5 69.3 0.748
Average 74.3 66.0 68.5 0.747
CV cortical volume, SV subcortical volume, CT cortical thickness, AD
Alzheimer’s disease, CTL healthy control, MCI mild cognitive
impairment and ICV intra cranial volume. 287 MCI subjects are
predicted on to the different AD versus CTL models, 87 MCI con-
verters and 200 MCI stable. Sensitivity = MCI converters predicted
as AD and specificity = MCI stable predicted as CTL. * Mixed
model = SV and CV normalized by ICV and raw CT data
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and PET markers is likely to further improve AD classifi-
cation and MCI conversion accuracy. This will hopefully
lead to improved tools to aid AD diagnosis and allow
targeting of the right populations for clinical trials.
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